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ABSTRACT
We report the sequence of a 7800 base pair region of herpes
simplex virus type 1 DNA, representing approximately 0.16 to
0.20 map units in the genome. This contains sequences
transcribed into a leftward oriented set of five 3' coterminal
mRNAs, together with two rightward transcribed flanking genes.
One of the leftward genes encodes the virus's alkaline
exonuclease, but the other gene products are uncharacterized.
The amino acid sequence of one encoded protein suggested that
it is a membrane embedded species. The DNA sequence is densely
utilised, with two predicted out-of-frame overlaps of coding
sequences, and probably six occurrences of promoter elements
within coding sequences. Homologues of five of the genes were
found for the distantly related Epstein-Barr virus, with a
similar overall relative arrangement.
INTRODUCTION
The genome of herpes simplex virus (HSV) is a linear double
stranded DNA of about 155,000 base pairs (1) and is thought to
possess about 80 genes. The genome contains several genes
specifying proteins involved in its replication, as well as
sequences which act as origins of DNA synthesis, and others
which are signals or sites in cutting and packaging of nascent
DNA (2,3). The HSV proteins which participate in DNA
replication include enzymes involved in the metabolism of DNA
precursors (for instance, thymidine kinase and ribonucleotide
reductase (4,5)), and also species more directly concerned with
DNA synthesis. The latter include a DNA polymerase, an
exonuclease and a polypeptide designated operationally as the
"major DNA binding protein" (6,7,8). As part of a large scale
sequence analysis of HSV-1 DNA, we recently reported the
sequences of the genes for DNA polymerase and the major DNA
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binding protein (9). In this paper, we describe the DNA
sequence of the exonuclease gene and of the neighbouring genes.
The exonuclease was first detected as an increased alkaline
nuclease activity present in HSV infected cells (10) and was
subsequently purified and shown to be a single polypeptide chain
(7,11,12,13), possessing both 5' and 3' exonuclease activity and
also an endonuclease activity (11,14,15). Analysis of
temperature sensitive mutants of the HSV-2 exonuclease gene has
shown that the enzyme is necessary for efficient replication of
virus DNA, although its precise role has not been defined
(16,17,18). The exonuclease gene was located in the long unique
region (UL: see Figure 1) of HSV-1 DNA, near 0.17 map units, by
hybrid arrest of translation of active enzyme (19). Analysis of
the transcript organization of this region of the genome has
shown that exonuclease mRNA is a member of a 3' coterminal set
of mRNAS (20). This paper reports a 7800 bp sequence containing
the whole of the 3' coterminal family, for HSV-1 strain 17,
together with all or part of the two flanking genes.
MATERIALS AND METHODS
(1) Plasmids.
Cloned restriction nuclease fragments of HSV-1 strain 17 DNA
were used for sequence analysis, as follows: EcoRI i and EcoRI d
in the EcoRI site of pACYC184, from V.G. Preston; and KpnI f and
KpnI
_
cloned into the PstI site of pAT153 by dG/dC tailing,
from A.J. Davison.
(2) Sequence analysis and interpretation.
DNA sequences were determined by M13/dideoxy methods, as
described (9,21,22). Computing was performed with a DEC PDP
11/44 under RSXllM, with programs as previously described
(9,22).
(3) Description of the HSV-l genome.
HSV genetic and mRNA mapping data commonly specify genome
locations in terms of fractional map units, running from 0.000
to 1.000. There exist significant discrepancies between the
numbering for HSV-1 strain 17 used by us and, for instance,
strain KOS (20,23); these are of the order of 0.005 map units or
800 bp. We deal with this, for the present, by quoting map
units as approximations to two decimal places only.
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Figure 1. Transcript arrangement of the HSV-1 genome, 0.16 to
0.20 map units. The upper part of the figure shows a
conventional representation of the HSV-1 genome, with major
repeat elements as open boxes, and the long and short unique
sequences (UL and US) as solid lines. The scale indicates
fractional genome length map units. In the lower part of the
figure an expansion is given for the region 0.16 to 0.20 map
units, with numbering in kb corresponding to Figure 2.
Locations and orientations of mRNAs are shown as arrows
(20,23,24), with predicted coding regions as open boxes. Note
that transcript b is hypothetical (see text). For transcript
., only the first exon and part of the intron region areincluded (23).
RESULTS
(1) organization of the HSV-1 genome, 0.16 to 0.20 map units.
E. Wagner's laboratory has mapped mRNA species transcribed
from HSV-1 DNA in the region 0.16 to 0.20 map units (20,23,24).
Figure 1 indicates the location of this region in UL, and
presents a transcript map based on their studies and on our
sequence data. It presently appears that all or part of at
least eight mRNA species originate from the region. For this
paper we have designated these a to h (Figure 1). RNAs b, c, d,
e and f form a leftward transcribed 3' coterminal family. The
two longest of these, e and f, were described as late
transcripts of 3.9 and 4.5 kb (20). d is an early 2.3 kb
transcript expressing the exonuclease (20). c is a late 1.9 kb
species (20). b is a species suggested by our sequence data and
is still hypothetical. These RNAs share a common
polyadenylation site. To the left of this 3' coterminal group,
RNA a is a 2 kb late, rightward transcribed species (24). To
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the right of the group, RNA j is a late, rightward 2.7 kb
transcript, with a large intron (23). Only the first exon is in
the region treated here. Within the intron region are 3'
coterminal, leftward transcripts (23); the downstream termini of
these are shown generically as h in Figure 1.
Organization in 3' coterminal families is a common feature
of HSV gene arrangement (22,24). It is thought that each RNA is
translated to give the polypeptide encoded adjacent to the 5'
terminus, while distal reading frames remain unused. Figure 1
also shows for mRNA species a to j the locations of the
proposed, corresponding protein coding regions, as deduced from
our DNA sequence data. These open reading frames were evaluated
using published mRNA mapping data (20,23,24), by analysis of
codon usage compared with known HSV genes (25), and by
comparisons with corresponding sequences from the genomes of
varicella-zoster virus (VZV) and Epstein-Barr virus (EBV). VZV
is, like HSV, a member of the alphaherpesvirinae sub-family
(26), although its DNA sequence and many details of genome
organization differ substantially from those of HSV. The
unpublished sequence of the corresponding region of the VZV
genome was made available to us by our colleague A.J. Davison.
EBV is a member of the gammaherpesvirinae, and its complete
genome sequence has been published (26,27).
We have determined the DNA sequence of HSV-1 strain 17 for
the region shown in Figure 1. This sequence is presented in
Figure 2 as 7800 bp, of base composition 65.2% G+C. Proposed
encoded amino acid sequences are also shown. The sequence was
determined by the M13/dideoxy system with random sub-fragments
of four large, plasmid cloned fragments of HSV-1 DNA (KpnI f and
_, and EcoRI d and j). KpnI f and _ lie to the left and right,
respectively, of the KpnI site at residue 5958 in Figure 2, and
EcoRI d and 2 lie to the left and right, respectively, of the
EcoRI site at 6670. The sequence as presented starts at an
arbitrary point to the left of the mRNA a region and ends
downstream of the mRNA i splice donor site. In the following
sections each gene is treated in turn.
(2) Gene "a" encodes a hydrophobic protein.
A rightward transcribed 2 kb mRNA has been mapped to the
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left of the exonuclease gene region (24). We consider that the
3' terminus of this RNA is near residue 2002 of Figure 2,
downstream of the appropriately placed polyadenylation consensus
AATAAA at 1977. The 5' terminus should therefore be near the
start of the sequence presented here, but has not been mapped
precisely. We propose that the protein coding region of gene a
starts with ATG at residue 538 and closes with TAG at 1957.
This reading frame of 473 codons encodes a protein of Mr 51389,
now termed 51K.
No known protein or function has been assigned clearly to
this gene. The encoded protein contains a high content of
hydrophobic amino acids (the three most abundant amino acid
species are Ala, Val and Leu), and also an excess of basic over
acidic residues. The hydrophobic residues are notably
clustered. There are at least five regions which, from their
degree of hydrophobicity and absence of charged residues, could
span a lipid bilayer membrane. We think it possible that 51K is
a previously undescribed, integral membrane protein, similar to
that encoded by HSV-1 near 0.74 map units which is involved in
virus-induced cell fusion (28). The 51K amino acid sequence
possesses low but definite homology with that of the EBV reading
frame BBRF3 (27) (see section 8, below).
(3) A possible small gene at the 3' end of the coterminal
family.
As described in the next section, mRNAs c, d, e and f have
their 3' termini near residue 2115. Upstream of this (on the
leftward 5'- 3' strand) lies the exonuclease coding region,
which terminates at TGA, residue 2343. There also exists a
small open reading frame overlapping the downstream end of the
exonuclease reading frame, out of phase, from ATG at 2425 to TAA
at 2137. This would encode a protein of 96 amino acids, Mr
10486, now called 10K. There is no mapped mRNA corresponding to
this reading frame. However, we think this small gene is
probably real, for the following reasons. Both EBV and VZV
possess corresponding open reading frames, with amino acid
sequence homology to the HSV-1 candidate. For the EBV example
(reading frame BBLF1), a promoter has been identified (27).
Lastly, the 10K reading frame shows a reasonable codon usage. A
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TACAACATCCGCGCTAGCGATACGCTCGACGTGTAC1
A R T A W W V W
GCGCGGACGGCGTGGTGGGTCTGG1
A T A S S Y A G
GCCACGGCGAGCTCTTATGCCOGGG
L L A V A V Y A
TTGTTGGCCGTGGCCGTGTATGCCO
A G N V C S W L
GCCGGAAACGTCTGCTCTTGGTTGC
H F C T R G V L
CATTTTTGCACCAGGGGGGTCCTGA
L L L G V F L C
TTGCTGTTGGGCGTCTTCCTGTGCA
I L V V S L L L
ATTCTCGTCGTATCGCTGTTGTTGG
H Y Y T N G Y Y
CACTATTACACCAACGGCTACTACG
T R A Y L Y H R
ACCCGCGCCTATCTGTATCACAGGC
C V O V
TGTGTGCAGGTG
V N S T
GTGAACTCCACG
V V G A
GTGGTCGGCGCO
L Q I T
CTGCAGATCACC
S G T Y
AGCGGGACGTAT
T A D A
AkCGGCCGACGCO
V V E G
GTGGTCGAGGGG
V V E T
GTTGTGGAGACG
R H H T
CGGCACCACACCJ
51K N Term
TGTTCGCACTCGTCGTCCCCA
A T F V V S A
GCGACGTTTGTGGTCTCTGCG(
A E V R G G V
GCCGAGGTGCGCGGGGGTGTA
V T S R Y D R
GTGACCTCCCGCTACGACCGC<
V L L L A H R
OTCCTGTTGCTGGCCCATCGC)
L R O V H G L
zTGCGTCAGGTGCACGGCCTGP
A V S L N T I
3CGGTATCCCTGAATACCATCI
V L C H Y V R
;TGTTGTGTCACTACGTGCGCI
G W P G A Q T
:AGTGGCCGGGGGCTCAGACG4
K F F M R AR
M G R P A P
kTGGGACGCCCGGCCCCC,
V C V T G L
;TCTGCGTCACGGGGCTC
A V P L R L
;CCGTGCCCCTCAGGTTG
A L D A G R
;CCCTGGACGCGGGCCGCC
I S 0 L A H
LTCAGCCAGCTGGCCCAC
M E L A P T
LTGGAGCTGGCCCCGACC
A A HN AN
;CCGCGTTCAACTTTAAT'
V L V G P H
;TGTTGGTGGGCCCCCACC
G V R V A L
GAGTCCGCGTCGCCCTCV
D T R H R A
R G S P
GAGGATCTCCC
L V L A
:TCGTCCTGGCC'
D T O S
;ACACGCAGAGC(
R L A A
:GTCTGGCTGCGC
L V Y V
TGGTTTACGTC(
H H R V
'ATCATCGCGTCO
F S A P
!TTTCGGCCCCGC
L G A V
:TGGGGGCCGTGC
A L V A
;CCCTGGTCGCC(
H S A L
D S A P P
;ACTCCGCGCCCCCCJ
S V F R A
rCTGTGTTCCGGGCA
L V G T Y
TTGTGGGCACTTAT
A R M A M
;CCCGCATGGCCATG(
L H F A C
TGCACTTTGCGTGT(
V G P A R
;TCGGCCCGGCTCGCC
G M L I C
;GCATGCTCATCTGC(
A A T G I
;CCGCCACGGGCATCC
A F A L G
;CCTTTGCCCTCGGC)
K R V R S
ZAAATTTTTTATGCGCATGCGCGACACGCGACACCGCGCACATTCCGCCCTCAAGCGCGTACGCAGTTC
;GTTGGGGCCCACGCGAT 120
GAACCGCGTCGCTAGGG 240
CATTGGCGCGCGGACCA 360
rCGGCCAAATCCCCCCCG 480
T K G M T G 21
kCGAAAGGCATGACCGGG 600
R F P C F Y 61
:GGTTTCCCTGCTTTTAC 720
V I T A V L 101
.ThATCACGGCCGTGTTG 840
P H A T L I 141
:CGCACGCCACGCTGATC 960
L V Y F A A 181
.TGGTGTATTTTGCGGCC 1080
A V L T N A 221
;CCGTGCTGACAAACGCC 1200
L T V L F A 261
TGACCGTGCTGTTCGCC 1320
V G L A C E 301
;TCGGCCTGGCCTGCGAG 1440
M A V L R C 341
LTGGCCGTGCTCCGCTGC 1560
S M R G S R 381
'CCATGCGCGGATCGCGA 1680
D G R H R P A P G S P P G I P E Y A E D P Y A I S Y G G I L D R Y G D S D G E P 421
GACGGCCGCCACAGGCCCGCACCCGGCAGCCCGCCCGGGATTCCCGAATATGCGGAAGACCCCTACGCGATCTCATACGGCGGCCAGCTCGACCGGTACGGAGATTCCGACGGGGAGCCG 1800
I Y D E V A D D Q T D V L Y A K I Q H P R H L P D D D P I Y D T V G G Y D P E P 461
ATTTACGACGAGGTGGCGGACGACCAAACCGACGTATTGTACGCCAAGATACAACACCCGCGGCACCTGCCCGACGACGATCCCATCTATGACACCGTTGGGGGGTACGACCCCGAGCCC 19210
A E D P V Y S T V R R W - 51K C Term ----- RNA a 3' Term 473
GCCGAGGACCCCGTGTACAGCACCGTCCGCCGTTGGTAGCTGTTTGGTTCCGTTTTAATA_ACCGTTTGTGTTTAACCCGACCGTGGTGTATGTCTGGTGTGTGGCGTCCGATCCCGTTA 2040
CTATCACCGTCCCCCCCCCCCCCTCAACCCCGGCGATTGTGGGTTTTTTAAAAACGACACGCGTGCGACCGTATACAGAACATTGTTTTGGTTTTTATTCGCTATCGGACATGGGGGGTG 2160
Coterminal A faily 3' Term - E S D S M P P P 89
1OK C Term
GAAACTGGGTGGCGGGGCAGGCGCCTCCGGGGGTCCGCCGGTGAGTGTGGCGCGAGGGGGGGTCCGATGAACGCAGGCGCTGTCTCCCCGGGGCCCGCGTAACCCCGCGCATATCCGGGG 2280
F Q T A P C A G G P T R R H T H R S P P D S S R L R 0 R G P A R T V G R M D P P 49
GCACGTAGAAATTACCTTCCTCTTr,CGACTCGATATCCACGACGTCAAAGTCGTGGGCGGTCAGCGA5.'.NCGACCTCCCCGTCGTCGGTGATGAGGACGTTGTTTCGGCAGCAGCAGGGCC 2400
V Y F N G E E E S e I D V V D F D H A T L S V V E G D D T I L V N N R C C C P R 9
Exo C Term - R S S R G T T P S S S T T E A A A P G 608
GGGCCCCGGAGAACGAGAGGCCCATAGCTCGGCGAGCGTGTCGTCGAATGCCAGGCGGCTGCTTCGCTGGATGGCC-TTATAGATCTCCGGATCGATGCGGACGGGGGTAATGATCAGG,GC 2520
A G S F S L G M IOK N Term 1
P G P S R S A W L E A L T D D F A L R S S R 0 I A K Y I E P D I R V P T I I L A 568
GATCGGAACGGCCTGGTTCGGGAGAATGGACGCCTTGCTGGGTCCTGCGGCCCCGAGAGCCCCGGCGCCGTCCTCCAGGCGGAACGTTACGCCCTCCTCCGCGCTGGTGCGGTGCCTGCC 2640
O N P L I S A
.AGATGCGGGTGGGGGGGGCAGTO
L H P H P P C D
ZCCGGAGCTCCAGGACACGGGGGAC
G S S W S V P S
ZCGCCTTTTTTCGCCCGAGGCGTGC
R R K E G S A H
ZCGGATAhATGCCCGGAACGCCTC
R I F A R F A E
,,TAAAAGGCCAGG43CGGTCTTGGGC
Y F A L P T K P
ZGTATGCACGTTCTCTTCGGCGAG
T H V N E E A L
OGCOGTCGGCTCGTTCACCCGCCCC
A T P E N V R G
3GTGGATGCGGTCOGTGAGGCCCCG
T S A T T L G R
CCGGGGGCCCGCGGCGCGTCAGGCGC
P P G R R T L R
HATGGCCAGAGOGOCGCGGACGCCO
I A L P A R V G
'TCCGGGGAGTCGGGATCGGCGTCO
D P S D P D A D
S P G A A G L A G A G D E L R F T V G e E A S T R
OGGGAAGTGGCTGTCGAGCACGTAOCCCTGCACCAAGATCTGCTTAAAGTTCGGGTGACGGGGGTTCGCGAAGAC
P F H S D L V Y GT V L IO K F N P H R P N A F V
;ATGGTGTGGCGTCCGAGGTCGGGGCGCCAAACAGAAGCACCTCCGAGACAACGCCGCTATTTAACTCCACCAA
I T H R G L D P A G F L L V E S V V G S N L E V L
OGCCTCTGACCAGGCCTGGTCTTGCGTGACGAGAGCCTCCTCCGGGCCGGGGACGCGCCCGGGCGCGAAGTATCG
A E S W A G D O T V L A E E P G P V R G P A F Y R
'GGGGACCGGTGTGCCATCAAGTCCTCGTACGCGGAGGCCGTGGGGTCGCTGGGOTCCATGGGGTCGAAAGCGTA(
P S R H A M L D E Y A S A T P D S P P D F A Y
;ACTGGGGCCAGGTAGCCGTGAATGTCCCGAGGACAGACGAGAATATCCAGGGACGCCCCGACCATCCCCGTGTGi
V P A L Y G H I D R P C V L I D L S A G V M G T H
;TCGCTGGGTTCGTGGAAGATAAAGCGCCGCGTOTCGGCGCCGGCCTCGCCGCCGTCGTCCGCGCGGCCCACGCAC
D S P E H F I F R R T D A G A E G G D A R G V C
;AACATCACCGCCGAAGACTGTACATCCGGCCGCAGGCTGGCOGTTGTGCTTCAGCCACTGGGGCGAGAAACACGG.
F M V A S S0 V D P R L S A N H K L W O P S F C P
:CGGAGCAGGGCCCATAGCTGGCAGTCGGCCTGGTTTTGCGTGGCCGCCTCGTAhAACCCCATGAGGGGCCGGGG
R L L A W L I C D A I N 0 T A A E Y F G M L P R P
:CATAGGTGCCGACCGAGTCCGCGGTCCACCATACCCGCCTCCTCGAGGACCACGGCCAGGGAACACAGATAATCC
W L H R G L G R D V A G A E E L V V A L S C L Y D
;CGCAGCAACCCGCGCAGGTGGCGCTCGAACGTCTCGGCTAGTATATGGGAGGGCAGCGCGTTGGGGATCACCGA(
R L L G R L H R E F T E A L I H S P L A N P I V S
:GGGTCGCGGGCGTGGGTGCCCCCAGGAGATAGOCGGhATGTCTGGGGTCGGAGGCCCTGAGGCGTCAGAAAGTGC(
P D R A H T G G P S L P I D P T P P G S A D S L A
H R G 528
'GCTCGCG 2760
P E R 488
'GCCCGATC 2880
A R D 448
'ACGCTGGG 3000
V S P 408
.TTGGCCCG 3120
K A R 368
kCCGTCCAT 3240
G D M 328
;TAGCGAAA 3360
Y R F 288
kCCCTGGGG 3480
G 0 P 248
'GCCACGGC 3600
A V A 208
'AGGCGGGC 3720
L R A 168
:GCCGACCA 3840
A S W 128
GGCGACGC 3960
P S A 88
GGCCCGGGGCTTTTCGTCTGCGGTGTCGGTGGCGTGCTGATCACGTGGCGGGGTTAACGG;GCGAATGGGAGCTCGGGTCCACAGCTGATGTCGTCTGGGGTGGGGGGGGCAGGGGACGGAA 4080
<-----0 *RNA c 5' Term
A R P K E D A T D T A H 0 D R P P N V P S H S S P D V A S T T 0 P P P P L P R F 48
GGTGGTTGTCAGCGGAAGACTGTTAGGGCGGGGGCGCTTGGGGGGGCTGTCGGGGCCACGAGGGGTGTCCTCGGCCAGGGCCCAGGGACGCTTAGTCACGGTGCGTCCCGGCGGACATGC 4200
T T T L P L S N P R P R K P P S D P G R P T D E A L A W P R K T V T R G P P C A 8
TGGGCCTACCGTGGACTCCATTTCCGAGACGACGTGGGGGGAGCGGTGGTTGAGCGCGCCGCCGGGTGAACGCTGATTCTCACGACAGCGCGTGCCGCGCGCACGGGTTGGTGTGACACA 4320
P G V T S E M Exo N Term 57K C Term - S L A H R A C P N T H C L 506
3440
I P V A
GATAAACGTCAC
I F T V
GCGGACCAGATCi
R V L D
CGCGGCGGAGCA
A A S C
CTTCGGGATCGA
K P I S
GCATTTGACCTO
C K V E
GAGGACCCCACAI
L V G C
CAGCAGGCTTCG
L L S R
GCCCCAGCGG.AG4
G W R L
GTCCGCGGCGGC
D A A A
CCAGAGGGG;ACC(
W L P G
CATAGAGTChAG
M S D L
:A(
rGI
:GA(
,G)
w
I
'GI
i
WC
GGI
;T
;G
'GI
:A7
GC
.G
IGI
3G
.G'
!G'
'cl
:G
kG
'G(
I
W)
Mc
cci
CO
KO
.A(
WC
3GI
I
'G)
I
;C(
I
;cc
.G(
I
,cc,
kc(
3G
3G(
CGJ
3GI
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GGCGGGACACCAGCACCAGGAGAGGCTTAAGCTCGGGAGGCAGCGCCACCGACGACAGTATCGCCTTGTGTGTGTGCTGGTAATTTATACACCGATCCGTAAACGCGCGCCGAATCTTGG 4440
<-----0 *RNA d 5 Term
R S V L V L L P K L E P P L A V S S L I A K H T H 0 Y N I C R D T F A R R I K P 466
GATTGCGGAGGTGGCGCCGGATGCCCTCTGGGACGTCATACGCCAGGCCGTGGGTGTTGGTCTCGGCCGAGTTGACAAACAGGGCTGGGTGCAGCACGCAGCGATAGGCGAGCAGGGCCA 44560
N R L H R R I G E P V D Y A L G H T N T E A S N V F L A P H L V C R Y A L L A L 426
GGGCGAAGTCCGGCGACAGCTGGTTGTTAAAATACTGGTAACCGGGAAACCGGGTCACGGGTACGCCC AGGCTCGGGGCGACGTACACGCTAACCACCAACTCCAGCAGCGTCTGGCCCA 4680
A F D P S L 0 N N F Y Q Y G P F R T V P V G L S P A V Y V H V V L E L L T 0 G L 386
GGGCGTACAGGTCAACCGCTAACCCGACGTCGTGCTTCAGGCGGTGGTTGGTAAATTCGGCCCGTTCGTTGTTAAGGTATTTCACCAACAGCTCCGGGGGCTGGTTATACCCGTGACCCA 4800
A Y L D V A L G V D H K L R H N T F E A R E N N L Y K V L L E P P Q N Y G H G V 346
CCAGGGTGTGAAAGTTGGCTGTGGTTAGGGCGGTGGGCATGCCAAACATCCGGGGGGACTTGAGGTCCGGCTCCTGGAGGCAAAACTGCCCCCGGGCGATCGTGGAGTTGGAGTTGAGGG 49420
L T H F N A T T L A T P M G F M R P S K L D P E 0 L C F 0 G R A I T S N S N L T 306
TGACGAGGCTAAAGTCGGCGAGGACGGCCCGCCGGAGCGAGACGGCGTCCGACCGCAGCATGACGAGGATGTTGGCGCACTTGATATCCAGGTGGCTGATCCCGCAGGTGGTGTTTAAAA 5040
V L S F D A L V A R R L S V A D S R L M V L I N A C K I D L H S I G C T T N L F 266
ACACAACGGCGCGGGCCAGCTCCGTGAAGCACTGGTGGAGGGCCGTCGAGACCGAGGGGTTTGTTGTGCGCAGGGACGCCAGTTGGCCGATATACTTACCGAGGTCCATGTCGTACGCGG 55160
V V A R A L E T F C 0 H L A T S V S P N T T R L S A L 0 G I Y K G L D H D Y A P 226
GGAACACTATCTGTCGTTGTTGCAGCGAGAACCCGAGGGGCGCGATGAAGCCGCGGATGTTGTGGGTGCGGCCGGCGCGTAGAACGCACTCCCCGACCAACAGGGTCGCGATGAGCTCAA 5280
F V I 0 R 0 0 L S F G L P A I F G R I N H T R G A R L V C E G V L L T A I L E V 186
CGGCAAACCACTCCTTTTCCTTTATGGTCTTAACGGCAAGCTTATGTTCGCGAATCAGTTGGACGTCACCGTATCCCCCAGACCCCCCGAAGCTTCGGGCCCCGGGGATCTCGAGGGTCG 5400
A F W E K E K I T K V A L K H E R I L 0 V D G Y G G S G G F S R A G P I E L T T 146
TGTAGTGTAGGGCGGGGTTGATGGCGAACACGGGGCTGCATAGCTTGCGGATGCGCGTGAGGGTGAGGATGTGCGAGGGGGACGAGGGGGGTGCGGTTAACGCCGCCTGGGATCTGCGCA 5520
Y H L A P N I A F V P S C L K R I R T L T L I H S P S S P P A T L A A Q S R R L 106
GGGGCGGGCGGTTCAGTTTGGCCGCCGTACCGGGCGTCTCGGGGGACGCGCGGCGATGAGACGAGCGGCTCATTCGCCATCGGGATAGTCCCGCGCGAAGCCGCTCGCGGAGGCCGGATC 5640
P P R N L K A A T G P T E P S A R R H S S R S M R W R S L G A R L R E R L G S R 66
23K C Term - E G D P Y D R A F G S A S A P D 200
GGTGGCGGGACCCGTGGGAGGAGCGGGAGACGGCGGCGTCCTGGAGAGAGGGGccGCTGGGGCGcccGGAGGccccGTGGGGGTTGGAGTGTAcGTAGGATGCGAGCCAATCCTTGAAGG 5760
H R S G H S S R S V A A D Q L S P G S P R G S A G H P N S H V Y S A L W D K F S 26
T A P G T P P A P S P P T R S L P A A P A G P P G T P T P T Y T P H S G I R S P 160
ACCGTTGGCGTGCACCTTGGGGGCTGAGGTTAGCTGCCACATGACCAGCAGGTCGCTGTCTGCGGGACTCATCCATCCTTCGGCCAGaTCGCCGTCTCCCCACAGAGAAGCGTrTGGTCGC 5880
R 0 R A G 0 P S L N A A V H G A P R 0 R R S E DO 57K N Term 1
G N A H V K P A S T L 0 W H V L L D S D A P S H W G E A L D G D G W L S A N T A 120
TGCTTCCTCGAGTTGCTCCTCCTGGTCCGCAAGACGATCGTCCACGGCGTCCAGGCGCTCACCAAGCGCCGGATCGAGGTACCGTCGGTGTGCGGTTAGAAAGTCACGACGCGCCGCTTG 6000
A E E L 0 E E Q D A L R D D V A D L R E G L A P D L Y R R H A T L F D R R A A 0 80
CTCCTCCACGCGAATTTTAACACAGGTCGCGCGCTGTCGCATCATCTCTAAGCGCGCGCGGGACTTTAGCCGCGCCTCCAATTCCAAGTGGGCCGCCTTTGCAGCCATAAAGGCGCCAAC 6120
<-----0 *RNA e S' Term
E E V R I K V C T A R 0 R H H E L R A R S K L R A E L E L H A A K A A H F A G V 40
mRNA g 5' Term 0----->
AAACCGAGGATCTTGGGTGCTGACGCCCTCCCGGTGCAGCTGCAGGGTCTGGTCCTTGTAAATCTCGGCTCGGAGGTCTCTCGGCCAGGCGTCGGCGCAGGGCCGCGTGGGCGGCATCTC 6240
F R P D O T S V G E R H L 0 L T Q D K Y I E A R L D R P W A D A C P R T P P H 1
23K N Term
U Term for R&A g product H F G 3
GGTCCATTCCGCCACCCTGCGGGCGACCCGGGGGGTGCTCTGATAGTCTCGCGTGCCCAAGGCCCGTGATCGGGGTACTTCGCCGCCGCGACCCGCCACCCGGTGTGCGCGATGTTTGGT 6360
O 0 L A S D V 0 0 Y L E R L E K 0 R 0 L K V G A D E A S A G L T M G G D A L R V 43
CAGCAGCTGGCGTCCGACGTCCAGCAGTACCTGGAGCGCCTCGAGAAACAGAGGCAACTTAAGGTGGGCGCGGACGAGGCGTCGGCGGGCCTCACCATGGGCGGCGATGCCCTACGAGTG 6480
P F L D F A T A T P K R H Q T V V P G V G T L H D C C E H S P L F S A V A R R L 83
CCCTTTTTAGATTTCGCGACCGCGACCCCCAAGCGCCACCAGACCGTGGTCCCTGGCGTCGGGACGCTCCACGACTGCTGCGAGCACTCGCCGCTCTTCTCGGCCGTGGCGCGGCGGCTG 6600
L F N S L V P A 0 L K G R D F G G D H T A K L E F L A P E L V R A V A R L R F K 123
CTGTTTAATAGCCTGGTGCCGGCGCAACTAAAGGGGCGTGATTTCGGGGGCGACCACACGGCCAAGCTGGAATTCCTGGCCCCCGAGTTGGTACGGGCGGTGGCGCGACTGCGGTTTAAG 6720
e C A P A D V V P 0 R N A Y Y S V L N T F 0 A L H R S E A F R 0 L V H F V R D F 163
GAGTGCGCGCCGGCGGACGTGGTGCCTCAGCGTAACGCCTACTATAGCGTTCTGAATACGTTTCAGGCCCTCCACCGCTCCGAAGCCTTTCGCCAGCTGGTGCACTTTGTGCGGGACTTT 6840
A 0 L L K T S F R A S S L T E T T G P P K K. R A K V D V A T H G R T Y G T L E L 203
GCCCAGCTGCTCAAAACCTCCTTCCGGGCCTCCAGCCTCACGGAGACCACGGGCCCCCCCAAAAAACGGGCCAAGGTGGACGTGGCCACCCACGGCCGGACGTACGGCACGCTGGAGCTG 6960
F 0 K M I L M H A T Y F L A A V L L G D H A E 0 V N T F L R L V F E I P L F S D 243
TTCCAAAAAATGATCCTTATGCACGCCACCTACTTTCTGGCCGCCGTGCTCCTCGGGGACCACGCGGAGCAGGTCAACACGTTCCTGCGTCTCGTGTTTGAGATCCCCCTGTTTAGCGAC 77080
A A V R H F R 0 R A T V F L V P R R H G K T W F L V P L I A L S L A S F R G I K 283
GCGGCCGTGCGCCACTTCCGCCAGCGCGCCACCGTGTTTCTCGTCCCCCGGCGCCACGGCAAGACCTGGTTTCTGGTGCCCCTCATCGCGCTGTCGCTGGCCTCCTTTCGGGGGATCAAG 7200
I G Y T A H I R K A T E P V F E E I D A C L R G W F G S A R V D H V K G E T I S 323
ATCGGCTACACGGCGCACATCCGCAAGGCGACCGAGCCGGTGTTTGAGGAGATCGACGCCTGCCTGCGGGGCTGGTTCGGTTCGGCCCGAGTGGACCACGTTAAAGGGGAAACCATCTCC 77320
F S F P D G S R S T I V F A S S H N T N V / Splice donor hite for RNA g 344
TTCTCGTTTCCGGACGGGTCGCGCAGTACCATCGTGTTTGCCTCCAGCCACAACACAAACGTAAGTCCTCTTTTCTTTCGCATGGCTCTCCCAAGGGGCCCCGGGTCGACCCGACCCACA 77440
CCCACCCACCCACATACACACACAACCAGACGCGGGAGGAAAGTCTGCCCCGTGGGCACTGATTTTTATTCGGGATCGCTTGAGGAGGCCCGGGCAACGGCCCGGGCAACGGTGGGGCAA 7 560
*RNA h 3' Term :-----
CTCGTAGCAAATAGGCGACTGATGTACGAAGAGAAGACACACAGGCGCCACCCG<;CGCTrGGTCGGGGGGATGTTGTCCGCGCCGCACCGTCCCCCGACGACCTCTATGCAGACGGTCCGTG 7680
ATGCAAGGACGGCGGGGGGCCTrGCAGCAGGGTGACCGTATCCACGGGATGGCCAAAGAGAAGCGGACACAGGCTAGCATCCCCCTGGaACCGCCAGGGTACACTGGGCCATCTrTGGCCCAC 7800
Figure 2. DNA sequence of the HSV-l genome, 0.16 to 0.20 map
units. The DNA sequence is shown for the expanded region of
Figure 1, as the rightward 5'-3' strand only. Precisely mapped
5' termini of mRNAs are shown as 0-----> (20,23), and presumed
3' termini as . :. Candidate polyadenylation sequences
AATAAA are underlined. Predicted amino acid sequences are
given in single letter code, with those from rightward 5'-3'
transcripts above the DNA sequence, and from leftward
transcripts below.
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hypothetical mRNA species (b) for this protein is indicated in
Figure 1.
(4) The exonuclease gene.
Costa et al. (20) have determined a 1000 bp sequence for
HSV-1 strain KOS, corresponding to residues 3656 - 4654 of
Figure 2. An extra residue is present at position 6 in the KOS
sequence (presumed an error), and there are 10 base
substitutions. Within this sequence Costa et al. mapped the 5'
termini of the mRNAs here called c and d. mRNA d encodes the
exonuclease and has its 5' terminus at position 4380 of Figure 2
(20). From the estimated size of RNA d (2.3 kb) it is clear
that the common 3' termini of this mRNA family lie near residue
2115, downstream of the polyadenylation consensus AATAAA at 2134
on the leftward 5'-3' strand.
We consider the exonuclease coding region runs from ATG at
4221 to TGA at 2343. This gives a protein of 626 amino acids,
Mr 67503, which corresponds moderately with a recent estimate of
the Mr from gel electrophoresis, of 85000 (13). The origin and
function of mRNA c, whose 5' terminus was mapped to position
3971 (20), are less clear. There is no obvious TATA box
upstream of RNA c's 5' terminus. Downstream of the 5' terminus,
the first two potential initiator ATG codons are at 3843 and,
174 nucleotides later, at 3669; both of these are in the
exonuclease assigned reading frame. It is therefore likely that
translation of RNA c would give rise to an N-terminally
truncated exonuclease protein. Starting from the first ATG, at
3843, the translation product would contain 500 amino acids,
with Mr 54395.
We have found that the exonuclease amino acid sequence is
clearly related to EBV reading frame BGLF5 (27) (see section 8,
below). Interestingly, however, the EBV sequence lacks residues
corresponding to approximately 110 amino acids at the N terminus
of HSV-1 exonuclease: that is, the EBV sequence is roughly
equivalent in extent to the 500 amino acid polypeptide proposed
to be translated from RNA c, reinforcing the notion that this
could be a functional protein.
(5) Upstream neighbour of the exonuclease gene.
In a limited sequence analysis, Costa et al. (23) located
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the 5' terminus of mRNA e at a position corresponding to residue
6025 (Figure 2), on the leftward 5'-3' strand. Curiously, this
is just upstream of the best nearby TATA box candidate, at 6013
to 6020. We think that translation of this mRNA starts with the
first ATG, at 5836, and ends with TGA at 4282. This would give
a protein of 518 amino acids, Mr 57193, now called 57K. This
assignment places the promoter, 5' terminus and part of the 5'
non coding region of the next downstream transcript, RNA d,
within the protein coding region of RNA e. This arrangement has
precedents in a number of other HSV genes (29,30). The 57K
amino sequence is homologous to that of the EBV reading frame
BGLF4.
Costa et al. (20) tentatively identified either RNA e or RNA
f as encoding a nucleocapsid protein designated VP19C. However,
they apparently confused VP19C with another species, VP18.8
(31,32), and we conclude that there is presently no firm
evidence as to the identity of 57K or of the RNA f product, 23K,
described next.
(6) The 5' member of the coterminal RNA family.
The largest member of the leftward reading 3' coterminal
family, RNA f, has been reported to be a 4.5 kb transcript (20).
The 5' terminus of RNA f has not been mapped precisely, but we
think it probable that it lies near 6470 or near 6590,
downstream of TATA candidate sequences at 6484 and 6604. The
most likely protein coding region runs from ATG at 6237 to TGA
at 5592, encoding a protein of 215 amino acids, Mr 23454, which
is now termed 23K. This assignment of RNA f's coding region
thus includes the promoter and 5' terminal region of RNA e, and
82 codons (out of phase) of the 57K coding sequence.
Arrangement of coding regions is proposed to be similar in the
corresponding region of the VZV genome (A.J. Davison, personal
communication). However, our interpretation should be regarded
as tentative, until these coding regions can be verified
experimentally.
(7) First exon of spliced RNA "g".
A major recent surprise in analysis of HSV's gene
organization was the description of a gene with a 4 kb intron,
within which were located genes in the opposite orientation
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HSV-1 51K versus EBV BBRF3
105 VA VYAVVGAVTSRYDRALDAG RRLAAARMAMPHAT LIAGNVCSWLLQITVLLLAHRISQLAHLVYVLHF
90 VAFIYYACGEVALIKARKKVSGLTDLSAWVSAVGSPTVLFLAILKLWSIQVFIQVLSYKH VFLSAFVYFLHF
174 ACLVYFAAHFCTRGVLSGTYLRQVHGLMELAPTHHRVVGPARAVLTNALLLGVFLCTADAAVSLNTIAAFNFNF
162 LASVLHACACVTRFSPVWVVKAO DNSIPODTFLWWVVFYLKPVVTNLYLGCLALETLVFSLSVFLALGNSFYF
248 SAPGMLICLTVLFAILVVSLLLVVEGVLCHYVRVLVGPHLGAVAATGIVGLACEHY
235 MVGDMVLGAVNLFLILPIFWYILTEVWLASFLRHNFGFYCGMFIASI ILILPLVRY
HSV-1 lOK versus ISBV BBLF1
1 MGLSFSGARPCCCRUNVLITDDGEVVSLTAHDFDVVDIESEEEGNFYVPPDMRGVTRAPG RQRLRSSDPPS
1 MGALWS LCRRRVNSIGDVDGGIINL YNDYEEFNLETTKLIAAEEGRACGETNEGLEYDEDS
HSV-1 Exonuclease versus EBV BGLF5
363 YEVKCRAKYAF DPMDPSDPTASAYEDLMAHRSPEAFRAFIRSIPKPSVRYFAPGRVPGPEEALVTQDQAWSE
224 YEIKCRFKYLPSKSEFDPIYPSYTALYKRPCKRS FIRFINSIARPTVEYVPDGRLPSEGDYLLTQDEAWNL
435 AHASGEKRRCSAADRA LVELNSGVVS EVLLFGAPDLGRHTISPVSWSSGDLVRREPV FANPRHPNFKQI
295 KDVRKRKLGPGHDLVADSLAANRGVESMLYVMTDPSENAGRIGI KDRVPVNIFINPRHNYFYQV
504 L VQGYVLDS HFPDCPPHPHLVT
359 LLQYKIVGDYVRHSGGGKPGRDCSPRVNIVT
HSV-1 57K versus EBV BGLF4
253 LHQCFTELARAVVFLNTTCGISHLDIKCANILVMLRSDAVSLRRAVLADFSLVTLNSNSTIARGQFCLQEPDLK
197 LVRGPQGLKDAVYFLNRHCGLFHSDISPSNIILVDFTDTMWGMGRLVLTDYGTASL HDRNKMLDVRLK
327 SPRMFGMPTALTTANFHTLVGHGYNQPPELLVKYLNNERAEFTNHRLKHDVG LAVDLYALGQTLL
264 SSKGRQLYRLYCQREPFSIAKDTYKPLCLLSKCYILRGAGHIPDPSACGPVGAQTALRLDL*SLGYSLL
Figure 3. Alignments of HSV-1 and EBV predicted amino acid
sequences. For four predicted HSV-1 amino acid sequences,
alignments are shown with corresponding EBV sequences (27), for
the most homologous regions only, as obtained with an alignment
optimising program (35). In each case the HSV-1 sequence is
the upper, and aligned identical residues are marked by
asterisks.
(23). The spliced mRNA is that denoted as the rightward
transcript a in Figure 1. The sequence of Figure 2 contains the
upstream exon only. Partial sequence data were presented for
this gene in HSV-1 strain KOS by Costa et al. (23). From their
results, the 5' terminus of the mRNA lies at 6136 and the first
exon ends with residue 7384 (Figure 2). Translation is thought
to start with ATG at 6352. Within the intron region, the 3'
termini of leftward transcribed mRNAs (denoted by h in Figure 1)
are near 7482, downstream of AATAAA at 7510. These assignments
place the promoters and 5' termini of the divergently
transcribed RNAs f and q each within the other's protein coding
region.
(8) Relations with genes of EBV.
The predicted amino acid sequences of the HSV-1 genes
described above were compared with predicted amino acid
sequences encoded in the EBV genome (27) by first using database
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Figure 4. Relations between HSV-1 and EBV genome
organizations. (a) The arrangement of reading frames from the
sequence of Figure 2 is shown, and is compared with reading
frames from the EBV sequence, residues 118501 to 126500 (27).
Homologous pairs are indicated by dashed lines. For HSV-1 the
reading frames, left to right, are for 51K, 10K, exonuclease,
57K, 23K and the first exon of the spliced gene. For EBV the
reading frames are BBRF3, BBLF1, BGLF5, BGLF4, BGLF3 and BGRF1
(27). (b) The positions of 4 groups of homologous genes are
compared in the two complete genomes. The position and
orientation of each gene is shown as ">" or "<". The HSV-1
groups are: near 0.2 map units, genes discussed in this paper;
near 0.4 map units, the gB, dbp, and p0 genes (10); and near
0.6 map units, genes for ribonucleotide reductase (30,36).
searching methods (33), then "matrix" comparisons (34), and
finally an optimal alignment program (35). These analyses
showed that HSV-1 genes encoding 51K, 10K, exonuclease and 57K
are homologous to EBV reading frames BBRF3, BBLF1, BGLF5 and
BGLF4, respectively. The homologies are low (less, for
instance, than that seen with HSV-1 and EBV DNA polymerases (9))
but are generally convincing. Figure 3 shows alignments of
parts of the four pairs of sequences exhibiting the most
conservation. In addition, the exons of the intron-containing
HSV-1 gene (j in Figure 1) have previously been shown to be
homologous to EBV's BGRF1 and BDRF1 (23). HSV-1 23K is presumed
to correspond to EBV BGLF3, from their positions relative to the
other reading frames, but no quantifiable amino acid sequence
homology was detected.
Thus, despite extensive divergent evolution, the region of
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the HSV-1 genome described in this paper, and the EBV genome
region, residues 119000 to 126000, are recognizably preserved in
gene layout and in encoded proteins, as shown in Figure 4(a).
When these data are combined with homology relations for HSV and
EBV ribonucleotide reductase proteins (36), and with our
previous comparison of the DNA polymerase regions (9), the
beginnings can be seen, in Figure 4(b), of an overall view of
relations between the genome organizations of the two viruses.
DISCUSSION
Our interpretation of protein coding regions in this part of
the HSV-1 genome, between 0.16 and 0.20 map units, indicates a
dense use of the DNA sequence. There are two proposed,
out-of-frame overlaps of coding sequences, of 27 and 82 codons,
and the remaining gaps between adjacent coding sequences are
minimal. In addition, since HSV promoters generally occupy
80-100 bp upstream from the cap site (37,38), it is clear that
the promoters for RNAs of the 3' coterminal family, and also the
promoter for RNA 1, must lie within protein coding sequences.
In the absence of direct information on amino acid sequences,
the identification of coding regions is, of course, subject to
errors of misinterpretation, and is also critically dependent on
the absence of frameshifting errors in the DNA sequence.
However, we regard our reading frame assignments as
conservative, and note that they are generally supported by
codon usage analysis and by comparison with evolutionarily
related sequences from EBV and VZV.
Of the seven predicted sequences, only that for the
exonuclease possesses any significant characterization. The
predicted occurrence of an N-terminally truncated exonuclease
fragment is intriguing, and the fact that EBV encodes a
homologue of about the same extent as this shortened protein
supports the notion that it could be functional. The 51K
protein is the only one of the unknowns whose sequence gives any
direct clue to its nature, in this case as a membrane-embedded
species. Finally, from the mapping results of Lemaster and
Roizman (31), one of our predicted species could be the virion
protein VP18.8, but this remains unresolved.
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The end result of our analyses is a clear view of gene
organization in this portion of HSV-1 DNA; this has been greatly
facilitated by the extensive mRNA mapping data of Costa et al.
(20,23). Some qualifications remain, and these will only be
resolved by extensive, further studies. We see the most
immediate of these as being, first, an evaluation of the
N-terminally truncated protein thought to be translated from RNA
c, and second, direct analysis of our proposed RNA b.
Our comparisons with EBV showed that the part of the HSV-1
genome examined shows general colinearity of organization with a
region of the EBV genome. Such colinearity also extends
rightward, at least in that the two genomes possess
correspondingly placed and homologous second exon sequences for
the rightward, spliced RNA j (23). However, Figure 4(b) shows
that larger scale rearrangements have certainly occurred during
the divergent evolution of these viruses.
This sequence will be deposited with the EMBL Sequence
Library.
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